CLOV vs ZBIO · rev $1.37B vs rev $5.0M
Clover Health Investments Corp (CLOV) versus Zenas BioPharma, Inc. Common Stock (ZBIO) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Zenas BioPharma, Inc. Common Stock (ZBIO) is a biotechnology company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported ZBIO revenue for 2024-12-31 was $5.0M. Net income was -$157.0M. Revenue was down 90.0% from 2023-12-31 to 2024-12-31. ZBIO currently screens at market cap $798.0M.
CLOV currently screens at market cap $1.55B. ZBIO currently screens at market cap $798.0M.
Not investment advice. Open the CLOV and ZBIO stock pages for the full models.
Not investment advice.